“Clinical outcomes and pathogenetic mechanisms of adjunctive ribonucleic acid therapy in adult patients with measles during the period of increased incidence in 2025–2026” (2026) Infectious Diseases – Infektsiyni khvoroby, (3), pp. 13–26. doi:10.11603/1681-2727.2026.3.16753.